Treatment of resistant aphthous ulceration with thalidomide in patients positive for HIV antibody.
作者信息
Youle M, Clarbour J, Farthing C, Connolly M, Hawkins D, Staughton R, Gazzard B
机构信息
St Stephen's Hospital, London.
出版信息
BMJ. 1989 Feb 18;298(6671):432. doi: 10.1136/bmj.298.6671.432.
Abstract
摘要
相似文献
1
Treatment of resistant aphthous ulceration with thalidomide in patients positive for HIV antibody.沙利度胺治疗HIV抗体阳性患者的耐药性阿弗他溃疡。
BMJ. 1989 Feb 18;298(6671):432. doi: 10.1136/bmj.298.6671.432.
2
Thalidomide for treatment of oral aphthous ulcers in patients with human immunodeficiency virus: case report and review.沙利度胺治疗人类免疫缺陷病毒感染者口腔阿弗他溃疡：病例报告及文献复习
Am J Gastroenterol. 1997 Jan;92(1):169-70.
3
Thalidomide-associated thrombosis in the treatment of HIV-associated severe aphthous disease: a case report and review of the literature.沙利度胺相关血栓形成在治疗HIV相关严重阿弗他病中的应用：一例病例报告及文献综述
J Int Assoc Physicians AIDS Care (Chic). 2012 Nov-Dec;11(6):345-7. doi: 10.1177/1545109712455460. Epub 2012 Aug 27.
4
Refractory aphthous ulceration treated with thalidomide: a report of 10 years' clinical experience.沙利度胺治疗复发性阿弗他溃疡：10 年临床经验报告。
Clin Exp Dermatol. 2012 Mar;37(2):132-5. doi: 10.1111/j.1365-2230.2011.04169.x. Epub 2011 Oct 18.
5
Thalidomide in oral aphthous ulceration in patients with HIV infection.沙利度胺用于HIV感染患者的口腔阿弗他溃疡
Palliat Med. 1994;8(3):255-6. doi: 10.1177/026921639400800311.
6
Recurrent aphthous ulcer in patient infected with human immunodeficiency virus: successful treatment with thalidomide.人类免疫缺陷病毒感染患者的复发性阿弗他溃疡：沙利度胺治疗成功
J Am Acad Dermatol. 1990 Sep;23(3 Pt 1):523-5. doi: 10.1016/s0190-9622(08)81115-2.
7
Thalidomide: treatment of severe recurrent aphthous stomatitis in patients with AIDS.
DICP. 1990 Nov;24(11):1054-6. doi: 10.1177/106002809002401105.
8
Thalidomide: treatment of choice for aphthous ulcers in patients seropositive for human immunodeficiency virus.沙利度胺：人类免疫缺陷病毒血清阳性患者复发性口腔溃疡的首选治疗药物。
J Am Acad Dermatol. 1993 Feb;28(2 Pt 1):271-2. doi: 10.1016/s0190-9622(08)81153-x.
9
[Thalidomide, the treatment of choice in aphthae in HIV infection].[沙利度胺，HIV感染中口腔溃疡的首选治疗药物]
Presse Med. 1990 Apr 14;19(15):722.
10
Thalidomide for aphthous ulcers in patients infected with the human immunodeficiency virus.
Am J Health Syst Pharm. 1996 Feb 15;53(4):368, 371-2, 378. doi: 10.1093/ajhp/53.4.368.
引用本文的文献
1
Thalidomide: an emerging drug in oral mucosal lesions.沙利度胺：一种用于口腔黏膜病变的新兴药物。
Clin J Gastroenterol. 2009 Jun;2(3):149-155. doi: 10.1007/s12328-009-0089-5. Epub 2009 Jun 2.
2
Topical treatments for HIV-related oral ulcers.用于治疗与HIV相关口腔溃疡的局部治疗方法。
Cochrane Database Syst Rev. 2012 Jan 18;1:CD007975. doi: 10.1002/14651858.CD007975.pub2.
3
Multiple myeloma.多发性骨髓瘤
Curr Probl Cancer. 2009 Jan-Feb;33(1):7-64. doi: 10.1016/j.currproblcancer.2009.01.001.
4
Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers.一项I期研究，旨在确定沙利度胺类似物CC-5013在转移性恶性黑色素瘤及其他晚期癌症患者中的安全性、耐受性和免疫刺激活性。
Br J Cancer. 2004 Mar 8;90(5):955-61. doi: 10.1038/sj.bjc.6601579.
5
Role of cytokines in AIDS wasting.细胞因子在艾滋病消瘦中的作用。
Nutrition. 1998 Nov-Dec;14(11-12):853-63. doi: 10.1016/s0899-9007(98)00108-7.
6
New roles for thalidomide.沙利度胺的新作用
BMJ. 1996 Aug 17;313(7054):377-8. doi: 10.1136/bmj.313.7054.377.
7
Thalidomide-induced neuropathy and genetic differences in drug metabolism.
Eur J Clin Pharmacol. 1995;49(1-2):1-6. doi: 10.1007/BF00192350.
8
Thalidomide: rationale for renewed use in immunological disorders.沙利度胺：在免疫性疾病中重新应用的理论依据。
Drug Saf. 1995 Jun;12(6):364-9. doi: 10.2165/00002018-199512060-00002.
9
Thalidomide--the way forward.沙利度胺——前进的道路。
Postgrad Med J. 1994 Dec;70(830):860-2. doi: 10.1136/pgmj.70.830.860.
10
Use of thalidomide in treatment and maintenance of idiopathic esophageal ulcers in HIV+ individuals.
Dig Dis Sci. 1995 May;40(5):1147-8. doi: 10.1007/BF02064213.
本文引用的文献
1
Thalidomide treatment of recurrent necrotic giant mucocutaneous aphthae and aphthosis.
Arch Dermatol. 1982 Nov;118(11):875.
2
Significant response of oral aphthosis to thalidomide treatment.
J Am Acad Dermatol. 1985 Jan;12(1 Pt 1):85-90. doi: 10.1016/s0190-9622(85)70014-x.
3
Thalidomide--effect on T cell subsets as a possible mechanism of action.沙利度胺——对T细胞亚群的影响作为一种可能的作用机制。
Int J Lepr Other Mycobact Dis. 1985 Jun;53(2):201-5.
4
Oral manifestations in patients with AIDS or AIDS-related complex.
Lancet. 1986 Aug 2;2(8501):288. doi: 10.1016/s0140-6736(86)92109-4.
Zotero 插件